Tissue Regenix Group (TRX)

 

TRX Share PerformanceMore

52 week high21.000 03/01/17
52 week low10.650 21/07/17
52 week change -7.720 (-40.10%)
4 week volume1,769,181 30/08/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Neil Woodford's trades in August 2017

After a busy summer for Neil Woodford, David Brenchley reveals what the star fund manager bought and sold last mon...

Notice of Results

RNS Number: 2015Q Tissue Regenix Group PLC 08 September 2017 Tissue Regenix Group plc Notice of Interim Results and Capital Markets Day Leeds, 8 September 2017 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company, today gives notice that it will announce its interim results for the six months ending...

Notification Of Major Holdings

RNS Number: 8912P Tissue Regenix Group PLC 05 September 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Tissue R...

Issue of Equity

RNS Number: 3527P Tissue Regenix Group PLC 30 August 2017 Tissue Regenix Group Plc Issue of equity and total voting rights Leeds, 30 August 2017 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "the Company"), the regenerative medical devices company,announces that it has today issued and allotted 711,083 ordinary shares of 0.5p each in the Compan...

Holding(s) in Company

RNS Number: 1729O Tissue Regenix Group PLC 16 August 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Tissue Rege...

Holding(s) in Company

RNS Number: 8288N Tissue Regenix Group PLC 11 August 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii TISSUE REGENIX GROUP PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voti...

Holding(s) in Company

RNS Number: 8286N Tissue Regenix Group PLC 11 August 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Tissue Rege...

Holding(s) in Company

RNS Number: 7070N Tissue Regenix Group PLC 10 August 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Tissue Reg...

Fundamental DataMore

EPS-1.27
Dividend yield0 %

Equity Research (TRX)

hardman & co
Tissue Regenix Group plc
10/08/2017
TRX has a broad portfolio of regenerative medicine products developed from decellularised human and porcine soft tissues for the wound care, orthopaedics, and cardiac markets. Since launch of...
hardman & co
Tissue Regenix Group Plc
17/03/2017
TRX has a broad portfolio of regenerative medicine products developed from decellularised human and porcine tissues for the wound care, orthopaedics, and cardiac markets. Sales of DermaPure have...
edison investment research
Tissue Regenix Group Plc
03/02/2017
Edison Investment Research is terminating coverage on Tissue Regenix Group (TRX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should...

Latest discussion posts More

  • Re: Hardman research

    On the other hand I didn't like the capitalisation of some of the R&D spend. I hope it relates to something patentable, or some capital equipment, otherwise it's just a con.
    15-Aug-2017
    Loldemort
  • Re: Hardman research

    I like the forecast of profitability by 2020 :-))) T P
    15-Aug-2017
    theprior
  • Re: Hardman research

    "Given that TRX?s US operations are based also in San Antonio, it is unsurprising that management intends to move its personnel into the CellRight building and to close its ...
    14-Aug-2017
    Loldemort

Users' HoldingsMore

Users who hold Tissue Regenix Group also hold..
LLOYDS GRP.35%
SIRIUS MINERALS24%
BP22%
TAYLOR WIMPEY20%
BT GROUP17%

Codes & Symbols

ISINGB00B5SGVL29
SymbolsTRX, LSE:TRX, TRX.L, TRX:LN, LON:TRX, XLON:TRX